Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:AACHOTCMKTS:GRSTNASDAQ:NIVFOTCMKTS:VYNT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAACHAAC$0.03+46.8%$0.03$0.01▼$0.84$805KN/A96,753 shs891,800 shsGRSTEthema Health$0.00+25.0%$0.00$0.00▼$0.00$3.09M1.784.39 million shs904,100 shsNIVFNewGenIvf Group$0.99-4.8%$2.40$0.85▼$656.00$550K-0.031.01 million shs32.97 million shsVYNTVyant Bio$0.19+7.8%$0.19$0.14▼$1.58$1.23M1.73161,822 shs19,100 shs10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAACHAAC0.00%0.00%0.00%0.00%0.00%GRSTEthema Health0.00%0.00%0.00%-20.00%-42.86%NIVFNewGenIvf Group+0.97%-4.59%-50.94%-82.81%-99.47%VYNTVyant Bio0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAACHAACN/AN/AN/AN/AN/AN/AN/AN/AGRSTEthema HealthN/AN/AN/AN/AN/AN/AN/AN/ANIVFNewGenIvf GroupN/AN/AN/AN/AN/AN/AN/AN/AVYNTVyant BioN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAACHAAC 0.00N/AN/AN/AGRSTEthema Health 0.00N/AN/AN/ANIVFNewGenIvf Group 0.00N/AN/AN/AVYNTVyant Bio 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAACHAACN/AN/AN/AN/AN/AN/AGRSTEthema Health$6.02M0.64N/AN/AN/A∞NIVFNewGenIvf Group$5.43M0.10N/AN/A($29.20) per share-0.03VYNTVyant Bio$670K1.83N/AN/A$1.69 per share0.11Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAACHAACN/AN/A0.00∞N/AN/AN/AN/AN/AGRSTEthema Health-$2.06MN/A0.00∞N/A-1.03%N/A-0.51%N/ANIVFNewGenIvf Group-$520KN/A0.00∞N/AN/AN/AN/AN/AVYNTVyant Bio-$22.69MN/A0.00∞N/A-3,474.81%-151.82%-97.14%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAACHAACN/AN/AN/AN/AN/AGRSTEthema HealthN/AN/AN/AN/AN/ANIVFNewGenIvf GroupN/AN/AN/AN/AN/AVYNTVyant BioN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAACHAACN/AN/AN/AGRSTEthema HealthN/A0.050.05NIVFNewGenIvf GroupN/A1.171.14VYNTVyant Bio0.042.862.86Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAACHAACN/AGRSTEthema HealthN/ANIVFNewGenIvf Group66.24%VYNTVyant BioN/AInsider OwnershipCompanyInsider OwnershipAACHAAC31.22%GRSTEthema Health55.75%NIVFNewGenIvf Group31.80%VYNTVyant Bio9.56%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAACHAAC1,90025.16 millionN/ANot OptionableGRSTEthema Health507.73 billion3.42 billionNot OptionableNIVFNewGenIvf GroupN/A530,000359,000N/AVYNTVyant Bio306.33 million5.72 millionNot OptionableAACH, GRST, NIVF, and VYNT HeadlinesRecent News About These CompaniesBio vs non-bio washing powderAugust 7, 2024 | which.co.ukWWhat is Biotechnology?August 4, 2024 | bio.orgBVyant Bio files Certificate of Dissolution with State of DelawareDecember 26, 2023 | msn.comVyant Bio Inc VYNTDecember 19, 2023 | morningstar.comMVyant Bio, Inc.: Vyant Bio Provides Update on Winddown ActivitiesNovember 11, 2023 | finanznachrichten.deVyant Bio expects to start liquidation payments in Q4 2024November 10, 2023 | msn.comVyant Bio Provides Update on Winddown ActivitiesNovember 10, 2023 | finance.yahoo.comVyant Bio, Inc.: Vyant Bio Announces Stockholder Approval of Plan of DissolutionNovember 1, 2023 | finanznachrichten.deVyant Bio shareholders approve plan to dissolve companyNovember 1, 2023 | msn.comVyant Bio Announces Stockholder Approval of Plan of DissolutionNovember 1, 2023 | finance.yahoo.comNamtu Airport, Namtu, Myanmar [ NMT / VYNT ]October 28, 2023 | prokerala.comPLab Notes: Philadelphia health care investment firm closes two funds valued at over $500MOctober 26, 2023 | finance.yahoo.comVyant Bio, Inc.: Vyant Bio Announces Completion of StemoniX Asset SaleOctober 25, 2023 | finanznachrichten.deVyant Bio Announces Completion of StemoniX Asset SaleOctober 24, 2023 | finance.yahoo.comVyant Bio Announces Stockholder Approval of Proposed Asset Sale; 64,110 Votes Needed to Approve Plan of Dissolution; and Adjournment of Special Meeting of StockholdersOctober 19, 2023 | finance.yahoo.comVyant Bio Announces 77,522 Votes Needed to Approve Sale of Assets 175,721 Votes Needed to Approve Winddown of Business Adjournment of Special Meeting of StockholdersOctober 11, 2023 | finance.yahoo.comVyant Bio, Inc.: Vyant Bio Announces Adjournment of Special Meeting of StockholdersSeptember 29, 2023 | finanznachrichten.deVyant Bio Announces Adjournment of Special Meeting of StockholdersSeptember 20, 2023 | finance.yahoo.comMedicare patients took unnecessary genetic cancer tests in man’s $463M scheme, feds sayAugust 21, 2023 | yahoo.comScientists identify four new breast cancer risk genesAugust 21, 2023 | devdiscourse.comDNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAACH, GRST, NIVF, and VYNT Company DescriptionsAAC OTCMKTS:AACH$0.03 +0.01 (+46.79%) As of 12/14/2020AAC Holdings, Inc. provides inpatient and outpatient substance use treatment services for individuals with drug addiction, alcohol addiction, and co-occurring mental/behavioral health issues in the United States. Its therapy services include motivational interviewing, cognitive behavioral therapy, rational emotive behavior therapy, dialectical behavioral therapy, solution-focused therapy, eye movement desensitization and reprocessing, and systematic family intervention. As of December 31, 2018, the company operated 11 inpatient substance abuse treatment facilities, focused on delivering clinical care and treatment solutions across 1,080 inpatient beds, including 700 licensed detoxification beds, 24 standalone outpatient centers, and 4 sober living facilities across 471 beds for a total of 1,551 combined inpatient and sober living beds. It also offers multi-media marketing services to families and individuals struggling with addiction and seeking treatment options through online directories of treatment providers, treatment provider reviews, forums, and professional communities. In addition, the company performs drug testing and diagnostic laboratory services; and provides physician services to its clients. AAC Holdings, Inc. was founded in 2014 and is headquartered in Brentwood, Tennessee. On June 20, 2020, AAC Holdings, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.Ethema Health OTCMKTS:GRST$0.0005 +0.00 (+25.00%) As of 11:38 AM EasternEthema Health Corporation operates behavioral healthcare space specifically in the treatment of substance use disorders. It offers rehabilitation services. The company was formerly known as GreeneStone Healthcare Corporation and changed its name to Ethema Health Corporation in April 2017. Ethema Health Corporation is based in West Palm Beach, Florida.NewGenIvf Group NASDAQ:NIVF$0.99 -0.05 (-4.81%) Closing price 04:00 PM EasternExtended Trading$0.97 -0.02 (-1.82%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company was founded by Siu Wing Fung and Fong Hei Yue on January 16, 2019 and is headquartered in Bangkok, Thailand.Vyant Bio OTCMKTS:VYNT$0.19 +0.01 (+7.78%) As of 12/29/2023Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). The company is based in Cherry Hill, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 2 Reasons to Buy Trade Desk Stock Now and 1 Warning Sign Toast Stock: A Fast-Growing Mid-Cap Eyeing Further Upside Breakout Alert: Disney Stock Hits Multi-Year High 2 Under the Radar Space & Defense Stocks With Huge Potential Palantir’s $100M Nuclear OS Pact Boosts Bullish Case Forget IBM: Accenture’s AI Momentum Is Your Next Buy Joby Stock Soars as Piloted Flights in Dubai Signal a New Era Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
